5-Azacitidine and Decitabine Epigenetic Therapy for Myeloid Malignancies

NCT04187703 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

RECRUITING

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Myelodysplastic Syndromes
MDS/MPN Crossover Syndromes

Interventions

DRUG: 5-azacytidine
DRUG: Decitabine

Sponsor

Benjamin Tomlinson